STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

CDLX CARDLYTICS INCORPORATED StockScouter® Report

5

StockScouter® Score

CARDLYTICS INCORPORATED, a micro cap value company in the technology sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • Short-term relative price momentum exhibits moderate strength. Postive/Neutral

 

Concerns

  • Moving average analysis for CDLX suggests weak price movement over the medium term. Negative
  • Two or more executives, directors or major shareholders – including one high-level executive –sold a small number of shares recently. Very negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, value stocks will be out of favor, and technology stocks will be out of favor.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

B
D
C
D

Previous Ratings

3
5
5